From: Therapeutic potential of ADAM10 modulation in Alzheimer’s disease: a review of the current evidence
Natural compound | Source | Model | Effect | Result | References |
---|---|---|---|---|---|
Curcumin | Curcuma longa | HEK293 cells overexpressing ADAM10 | Increase ADAM10 expression | Increase sAPPα production and exert neuroprotective effects | [107] |
Icariin | Epimedium brevicornum | Rat model of permanent occlusion of bilateral common carotid arteries | Reduce BACE1 and increase ADAM10 expression | Decrease in the level of insoluble Aβ fragments | [108] |
Astaxanthin | Euphausia pacifica | 3xTg AD mice | Induce ADAM10 expression | Up-regulation of non-Amyloidogenesis pathway | [109] |
Epigallocatechin-3-gallate | Green tea | SweAPP N2a cells | Increase active form of ADAM10 (∼ 60 kDa mature form) | Increase sAPPα production and exert neuroprotective effects | [110] |
SweAPP N2a cells | Activation of ADAM10 through the PI3K/AKT pathway activation | Increase sAPPα production and exert neuroprotective effects | [111] | ||
Resveratrol | Polygonum cuspidatum | CHO-APPswe cells | Augment altered expression and subcellular localization of ADAM10 induced by high cholestrol | Up-regulation of non-Amyloidogenesis pathway | [112] |
Bilobalide | Ginkgo biloba | Differentiated SH-SY5Y cell | Induction of ADAM10 through the PI3K/AKT pathway activation | Increase sAPPα production and exert neuroprotective effects | [113] |
Quercetin | Hypericum perforatum | Aluminum chloride -induced AD rat model | Up-regulation of ADAM10 | Inhibit Aβ aggregation | [114] |
Ligustilide | Angelica sinesis | APP/PS1 mice | Up-regulation of ADAM10 | Inhibit Aβ aggregation | [115] |
Cryptotanshinone | Salvia miltiorrhiza | N2a-SwedAβPP cells | Activation and translocation of ADAM10 and PKC-alpha | Up-regulation of non-Amyloidogenesis pathway | [116] |
Berberine | Berberis vulgaris | APP/PS1 transgenic mice | Increase ADAM10 expression | Reduce Aβ deposition and improve memory function | [117] |